Key facts
- 52-week range (closes)
- $367.70 – $534.56 Lowest close Sep 15, 2026, highest May 26, 2026; 251 daily closes to Oct 13, 2026 from Dalsna Finance's price archive
- Fiscal year ends
- October Fiscal 2025 ended Oct 31, 2025, from SEC filings
- In the S&P 500 since
- Mar 16, 2017, replacing Harman International (HAR) · Samsung Electronics acquired Harman International Industries. · All S&P 500 changes
- In the Nasdaq-100 since
- Dec 18, 2017, replacing Akamai Technologies (AKAM), Discovery Communications Series A (DISCA), Discovery Communications Series C (DISCK), Norwegian Cruise Line Holdings (NCLH), Tractor Supply (TSCO) and Viacom (VIAB) · Annual index reconstitution. · Annual index reconstitution. Norwegian Cruise Line was dropped due to transferring its listing from NASDAQ to the NYSE. · All Nasdaq-100 changes
- Analyst coverage
- 5 open price targets from 5 firms: Deutsche Bank, HSBC, Morgan Stanley, Rosenblatt Securities, Wells Fargo Approved targets tracked here; see the analyst section below
Synopsys (SNPS) is trading down at $447.62 (-1.53%) on NASDAQ, as of the latest quote. It is a S&P 500 constituent in the Information Technology sector.
Analyst price targets on SNPS
Current price targets from 5 firms average $578, median $575, ranging from $475 to $700 — the average is 29% above the current $448. Each is tracked to its date and scored the same way a member's call is.
- Deutsche Bank $491 → $640 by Oct 2027 Oct 1, 2026 via Barchart.com · Deutsche Bank's track record
- HSBC $426 → $700 by Sep 2027 Sep 25, 2026 via Investing.com · HSBC's track record
- Wells Fargo $397 → $475 by Sep 2027 Sep 10, 2026 via Yahoo Finance · Wells Fargo's track record
- Morgan Stanley $392 → $500 by Sep 2027 Sep 8, 2026 via Investing.com · Morgan Stanley's track record
- Rosenblatt Securities $409 → $575 by Aug 2027 Aug 25, 2026 via Investing.com · Rosenblatt Securities's track record
Targets published by research firms, extracted from the news, checked against independent reporting, and linked to their source. Where a firm did not state a horizon the target is tracked as 12 months, the industry convention; the rows where the firm set its own horizon are marked. Reported here as facts about what was published — not recommendations from Dalsna Finance, and no firm listed is affiliated with this site.
Synopsys revenue & net income history (FY2016–FY2025)
| FY2016Oct 2016 | FY2017Oct 2017 | FY2018Oct 2018 | FY2019Oct 2019 | FY2020Oct 2020 | FY2021Oct 2021 | FY2022Oct 2022 | FY2023Oct 2023 | FY2024Oct 2024 | FY2025Oct 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $2.42B | $2.72B | $3.12B | $3.36B | $3.69B | $4.20B | $5.08B | $5.32B | $6.13B | $7.05B |
| Growth (year over year) | +8.0% | +12.5% | +14.5% | +7.7% | +9.7% | +14.1% | +20.9% | +4.7% | +15.2% | +15.1% |
| Gross profit | $1.88B | $2.07B | $2.39B | $2.61B | $2.89B | $3.34B | $3.72B | $4.29B | $4.88B | $5.43B |
| Gross margin | 77.6% | 76.0% | 76.4% | 77.6% | 78.4% | 79.5% | 73.2% | 80.6% | 79.7% | 77.0% |
| Operating income | $317.4M | $347.6M | $360.2M | $520.2M | $620.1M | $734.8M | $1.15B | $1.27B | $1.36B | $914.9M |
| Operating margin | 13.1% | 12.8% | 11.5% | 15.5% | 16.8% | 17.5% | 22.6% | 23.9% | 22.1% | 13.0% |
| Net income | $266.8M | $136.6M | $432.5M | $532.4M | $664.3M | $757.5M | $984.6M | $1.23B | $2.26B | $1.33B |
| Net margin | 11.0% | 5.0% | 13.9% | 15.8% | 18.0% | 18.0% | 19.4% | 23.1% | 36.9% | 18.9% |
| EPS (diluted) | $1.73 | $0.88 | $2.82 | $3.45 | $4.27 | $4.81 | $6.29 | $7.92 | $14.51 | $8.04 |
| Balance sheet | ||||||||||
| Cash and equivalents | $976.6M | $1.05B | $723.1M | $728.6M | $1.24B | $1.43B | $1.42B | $1.43B | $3.90B | $2.89B |
| Total assets | $5.24B | $5.40B | $6.15B | $6.41B | $8.03B | $8.75B | $9.42B | $10.3B | $13.1B | $48.2B |
| Total liabilities | $2.05B | $2.12B | $2.66B | $2.32B | $3.12B | $3.45B | $3.86B | $4.15B | $4.05B | $19.9B |
| Long-term debt | $0 | $134.1M | $125.5M | $120.1M | $100.8M | $25.1M | $20.8M | $18.1M | $15.6M | $13.5B |
| Shareholders' equity | $3.20B | $3.28B | $3.48B | $4.08B | $4.91B | $5.30B | $5.52B | $6.15B | $8.99B | $28.3B |
| Cash flow | ||||||||||
| Operating cash flow | $586.6M | $632.5M | $424.4M | $800.5M | $991.3M | $1.49B | $1.74B | $1.70B | $1.41B | $1.52B |
| Capital expenditure | $66.9M | $70.3M | $99.0M | $198.1M | $154.7M | $93.8M | $136.6M | $189.6M | $139.5M | $169.5M |
| Free cash flow | $519.7M | $562.2M | $325.4M | $602.4M | $836.6M | $1.40B | $1.60B | $1.51B | $1.27B | $1.35B |
| Share buybacks | $400.0M | $380.0M | $400.0M | $329.2M | $242.1M | $753.1M | $1.10B | $1.16B | $0 | $0 |
| Q4 FY24†Oct 2024 | Q1 FY25Jan 2025 | Q2 FY25Apr 2025 | Q3 FY25Jul 2025 | Q4 FY25†Oct 2025 | Q1 FY26Jan 2026 | Q2 FY26Apr 2026 | Q3 FY26Jul 2026 | |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $1.64B | $1.46B | $1.60B | $1.74B | $2.25B | $2.41B | $2.28B | $2.48B |
| Growth (year over year) | +22.1% | −3.7% | +10.3% | +14.0% | +37.8% | +65.5% | +41.9% | +42.4% |
| Gross profit | $1.26B | $1.19B | $1.29B | $1.36B | $1.60B | $1.77B | $1.65B | $1.80B |
| Gross margin | 77.1% | 81.4% | 80.2% | 78.1% | 71.0% | 73.5% | 72.3% | 72.6% |
| Operating income | $310.8M | $251.8M | $376.4M | $165.3M | $121.4M | $203.0M | $120.4M | $357.5M |
| Operating margin | 19.0% | 17.3% | 23.5% | 9.5% | 5.4% | 8.4% | 5.3% | 14.4% |
| Net income | $1.11B | $295.7M | $345.3M | $242.5M | $448.7M | $65.0M | $17.1M | $545.8M |
| Net margin | 68.1% | 20.3% | 21.5% | 13.9% | 19.9% | 2.7% | 0.8% | 22.0% |
| EPS (diluted) | $7.13 | $1.89 | $2.21 | $1.50 | $2.44 | $0.34 | $0.09 | $2.84 |
| Balance sheet | ||||||||
| Cash and equivalents | $3.90B | $3.65B | $14.1B | $2.53B | $2.89B | $2.13B | $2.41B | $3.61B |
| Total assets | $13.1B | $13.0B | $23.8B | $48.2B | $48.2B | $47.2B | $46.9B | $47.7B |
| Total liabilities | $4.05B | $3.74B | $13.8B | $20.6B | $19.9B | $16.7B | $16.4B | $16.6B |
| Long-term debt | $15.6M | $14.2M | $10.0B | $14.3B | $13.5B | $10.0B | $10.0B | $9.02B |
| Shareholders' equity | $8.99B | $9.30B | $9.92B | $27.6B | $28.3B | $30.5B | $30.5B | $31.2B |
| Cash flow | ||||||||
| Operating cash flow | $562.8M | −$67.5M | $275.4M | $671.0M | $639.7M | $856.8M | $628.9M | $812.8M |
| Capital expenditure | $20.7M | $40.7M | $55.6M | $38.6M | $34.5M | $35.3M | $54.2M | $66.6M |
| Free cash flow | $542.1M | −$108.2M | $219.8M | $632.4M | $605.2M | $821.5M | $574.7M | $746.3M |
| Share buybacks | $0 | — | — | $0 | $0 | — | — | $37.5M |
From Synopsys's 10-K and 10-Q filings with the SEC; its fiscal year ends in October. Each period shows the latest figure the company has reported for it, including restatements. Net margin is our own calculation from those reported figures (net income ÷ revenue); it is left blank where revenue is zero or missing. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →
Synopsys vs the Information Technology sector and the S&P 500
Synopsys's latest reported figures next to the median of the other 75 S&P 500 Information Technology companies and of the other 502 S&P 500 companies; each median is taken over the companies with a comparable figure (counts in the footnote). A median is the middle value, not an average, so one very large company does not move it.
| Measure | Synopsys | Information Technology (75 other S&P 500 companies) | S&P 500 (502 other companies) |
|---|---|---|---|
| Revenue growth, latest fiscal year | +15.1% | +13.7% | +7.0% |
| Net margin, latest fiscal year | 18.9% | 16.5% | 12.9% |
| Share price change, 1 year | +0.3% | +14.8% | +5.9% |
Synopsys: fiscal year ended October 2025, from its 10-K and 10-Q filings with the SEC. Medians computed October 20, 2026 from each company's latest annual filing (fiscal years ending between July 2025 and September 2026) and our price archive. Prices for every company, Synopsys included, are the last regular-session prices of October 19, 2026; the 1-year change compares that price with each company's last close on or before October 20, 2025. Net margin and price change are our calculations from reported figures. Each median counts only the companies with a comparable figure (sector / S&P 500): revenue growth 75/496, net margin 75/496, 1-year price change 67/490; the reasons below can overlap. 12 are left out of the price figure because our archive holds no comparable close for them. The S&P 500 price figure is the middle company's change, not the index's return.
About Synopsys
Synopsys, Inc. is an American multinational electronic design automation (EDA) company headquartered in Sunnyvale, California, that focuses on design and verification of silicon chips, electronic system-level design and verification, and reusable components. Synopsys supplies tools and services to the semiconductor design and manufacturing industry. Products include tools for implementation of digital and analog circuits, simulators, and debugging environments that assist in the design of chips and computer systems. In 2024, Synopsys was listed as the 12th largest software company in the world.
- Headquarters
- Sunnyvale, California From SEC filings, Oct 2026
Recent News (20)
-
Synopsys CEO Ghazi Sassine sells $6.7m in stock
Synopsys CEO Ghazi Sassine sells $6.7m in stock
-
Is Synopsys Back from the Dead? EDA Leader Inks Deals With Amazon and OpenAI Is Synopsys Back from the Dead? EDA Leader Inks Deals With Amazon and OpenAI MarketBeat
-
Zacks Investment Ideas feature highlights: Synopsys and Amazon Zacks Investment Ideas feature highlights: Synopsys and Amazon The Globe and Mail
-
Synopsys GC Janet Lee sells $574,685 in company stock
Synopsys GC Janet Lee sells $574,685 in company stock
-
Microelectronics US Announces Steering Committee Ahead of Inaugural 2027 Austin Event Leaders from NVIDIA, AWS, Siemens, GlobalFoundries, Synopsys, Honeywell, Cisco, Ericsson and more will help shape the May 4–5, 2027 event AUSTIN, Texas, Oct. 7, 2026 /PRNewswire/ -- Microelectronics U…
-
Synopsys deputy CFO & CAO Kankanwadi sells over $6m in stock
Synopsys deputy CFO & CAO Kankanwadi sells over $6m in stock
-
Synopsys vs Cadence: valuation, cash flow, and pairs trade compared
Synopsys vs Cadence: valuation, cash flow, and pairs trade compared
-
-
-
-
-
Amazon Inks $1B SNPS Deal to Power AWS Custom Chips: Should You Hold? Amazon Inks $1B SNPS Deal to Power AWS Custom Chips: Should You Hold? The Globe and Mail
-
Stocks making the biggest moves midday: Accenture, Synopsys, United Therapeutics, Vicor and more Stocks making the biggest moves midday: Accenture, Synopsys, United Therapeutics, Vicor and more CNBC
-
-
Synopsys shares jump on robust growth outlook, OpenAI and AWS deals
Synopsys shares jump on robust growth outlook, OpenAI and AWS deals
-
Synopsys shares jump on robust growth outlook, OpenAI and AWS deals Synopsys shares jump on robust growth outlook, OpenAI and AWS deals Reuters
-
-
Synopsys options flow turns bullish on AWS deal and OpenAI partnership
Synopsys options flow turns bullish on AWS deal and OpenAI partnership
-
Why is Synopsys stock rallying today?
Why is Synopsys stock rallying today?
-
Synopsys, Amazon Web Services sign chip design licensing deal worth more than $1 billion
Synopsys, Amazon Web Services sign chip design licensing deal worth more than $1 billion
More Information Technology stocks
- ROP Roper Technologies
- SHOP Shopify
- SMCI Supermicro
- SNDK Sandisk
- STX Seagate Technology
- SWKS Skyworks Solutions
- TDY Teledyne Technologies
- TEL TE Connectivity